HQY Healthequity Inc

Price (delayed)

$80.29

Market cap

$6.92B

P/E Ratio

123.52

Dividend/share

N/A

EPS

$0.65

Enterprise value

$7.45B

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who ...

Highlights
HQY's EPS has surged by 91% since the previous quarter
HQY's net income has surged by 91% since the previous quarter
HQY's quick ratio has surged by 62% year-on-year but it is down by 2.7% since the previous quarter

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
86.16M
Market cap
$6.92B
Enterprise value
$7.45B
Valuations
Price to book (P/B)
3.39
Price to sales (P/S)
6.87
EV/EBIT
57.07
EV/EBITDA
26.26
EV/Sales
7.45
Earnings
Revenue
$999.59M
EBIT
$130.5M
EBITDA
$283.57M
Free cash flow
$200.01M
Per share
EPS
$0.65
Free cash flow per share
$2.34
Book value per share
$23.72
Revenue per share
$11.68
TBVPS
$7.94
Balance sheet
Total assets
$3.16B
Total liabilities
$1.13B
Debt
$933.14M
Equity
$2.04B
Working capital
$440.35M
Liquidity
Debt to equity
0.46
Current ratio
4.76
Quick ratio
4.35
Net debt/EBITDA
1.87
Margins
EBITDA margin
28.4%
Gross margin
62.3%
Net margin
5.6%
Operating margin
11.8%
Efficiency
Return on assets
1.8%
Return on equity
2.8%
Return on invested capital
12%
Return on capital employed
4.3%
Return on sales
13.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
1.58%
1 week
-0.74%
1 month
1.02%
1 year
49.15%
YTD
21.1%
QTD
-1.64%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$999.59M
Gross profit
$622.64M
Operating income
$117.7M
Net income
$55.71M
Gross margin
62.3%
Net margin
5.6%
HQY's net income has surged by 91% since the previous quarter
The net margin has surged by 87% since the previous quarter
HQY's operating income is up by 28% since the previous quarter
The gross profit rose by 27% year-on-year and by 5% since the previous quarter

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
123.52
P/B
3.39
P/S
6.87
EV/EBIT
57.07
EV/EBITDA
26.26
EV/Sales
7.45
HQY's EPS has surged by 91% since the previous quarter
The stock's P/B is 15% above its last 4 quarters average of 2.9 but 8% below its 5-year quarterly average of 3.6
The equity has grown by 7% YoY and by 2.4% from the previous quarter
HQY's revenue is up by 16% year-on-year and by 2.9% since the previous quarter
The stock's price to sales (P/S) is 13% more than its last 4 quarters average of 6.0 but 12% less than its 5-year quarterly average of 7.7

Efficiency

How efficient is Healthequity business performance
The ROA has soared by 100% from the previous quarter
The ROE has soared by 87% from the previous quarter
HQY's ROIC is up by 30% QoQ
HQY's return on sales is up by 26% since the previous quarter

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 180% higher than its total liabilities
Healthequity's current ratio has surged by 63% YoY but it has decreased by 3.4% QoQ
HQY's quick ratio has surged by 62% year-on-year but it is down by 2.7% since the previous quarter
The debt is 54% smaller than the equity
The debt to equity has declined by 12% year-on-year and by 2.1% since the previous quarter
The equity has grown by 7% YoY and by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.